AstraZeneca vaccine scientists set for £22m payday in New York float Rupert Neate Wealth correspondent
Prof Sarah Gilbert, the Oxford University scientist who lead the team that created the Oxford/AstraZeneca coronavirus vaccine, is set for a payday of more than £20m as the vaccine technology firm she co-founded prepares to float on the New York stock exchange.
Popular Searches
Gilbert, who became a household name as a result of her work creating Oxford’s Covid-19 vaccine, owns just over 5% of Vaccitech, a Oxford University spin-out company that owns the biotechnology behind the AstraZeneca coronavirus vaccine and others for Mers, hepatitis B, the virus that causes shingles, and a range of cancers.
Professor Sarah Gilbert to net $20m after Oxford vaccine start-up makes US debut
telegraph.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from telegraph.co.uk Daily Mail and Mail on Sunday newspapers.
AstraZeneca vaccine scientists set for £22m payday in New York float
theguardian.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theguardian.com Daily Mail and Mail on Sunday newspapers.
Vaccitech Appoints Joseph Scheeren, PharmD, to its Board of Directors
globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.